Tiansheng Pharmaceutical Group Co Ltd (002872) — Capital Reinvestment Ratio
Tiansheng Pharmaceutical Group Co Ltd (002872) has a Capital Reinvestment Ratio of 0.30x as of March 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.79 Million) in capital expenditures (CN¥9.44 Million). See 002872 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tiansheng Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Tiansheng Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check Tiansheng Pharmaceutical Group Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see Tiansheng Pharmaceutical Group Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.00x | CN¥50.15 Million | CN¥50.27 Million | ▲ +21.8% |
| 2022 | 0.82x | CN¥89.18 Million | CN¥73.42 Million | ▼ -86.3% |
| 2021 | 6.03x | CN¥18.97 Million | CN¥114.38 Million | ▲ +1134.1% |
| 2020 | 0.49x | CN¥189.75 Million | CN¥92.70 Million | ▼ -24.4% |
| 2019 | 0.65x | CN¥144.21 Million | CN¥93.24 Million | ▼ -57.5% |
| 2018 | 1.52x | CN¥153.99 Million | CN¥234.27 Million | ▲ +81.0% |
| 2016 | 0.84x | CN¥506.68 Million | CN¥425.96 Million | ▼ -34.7% |
| 2015 | 1.29x | CN¥213.54 Million | CN¥274.87 Million | ▼ -25.2% |
| 2014 | 1.72x | CN¥191.99 Million | CN¥330.32 Million | ▼ -22.3% |
| 2013 | 2.21x | CN¥57.06 Million | CN¥126.34 Million | ▲ +74.0% |
| 2012 | 1.27x | CN¥145.06 Million | CN¥184.63 Million | — |